More than 5 million people in the U.S. have Alzheimer’s disease – a major cause of cognitive decline – and this number is expected to almost triple to 16 million by 2050. With figures like these, the race is on to find a cure for the disease.

In a new study, a researcher describes a novel, personalized treatment program that he claims has reversed cognitive decline in a small number of patients with memory loss.

READ FULL ARTICLE Curated publisher From Medical News Today